Eydenzelt is a vascular endothelial growth factor inhibitor referencing Eylea, which is jointly developed by Regeneron ...

Libtayo gained FDA approval as the first immunotherapy for high-risk cutaneous squamous cell carcinoma, promising improved ...

Regeneron gests US FDA approval for Libtayo as an adjuvant treatment of CSCC with a high risk of recurrence after surgery and radiation: Tarrytown, New York Friday, October 10, 20 ...

This is a developing news story. Please check back soon for updates. The FDA approved Eydenzelt, a biosimilar referencing ...

Roche Holding AG has completed early tests of its ability to produce large quantities of Regeneron Pharmaceuticals Inc's COVID-19 antibody treatment, putting it on track to begin manufacturing the ...

In today’s Pharmaceutical Executive Daily, we cover Bristol Myers Squibb’s $1.5 billion acquisition of Orbital Therapeutics, ...

Samsung BioLogics Co Ltd on Tuesday said it is mass-producing a COVID-19 antibody treatment developed by Eli Lilly and Co , as the United States began distributing the drug last week after ...

Novo Nordisk will buy Akero Therapeutics for up to $5.2 billion. Chiesi Group announced a deal potentially worth $2 billion with Arbor Biotechnologies to license and develop its gene editing therapy.

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals recently ...

Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals, in ...

LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential ...

The body's tissues can get injured in many ways, but while some injuries heal perfectly, others don't heal at all. A cut in ...